Breakthroughs that break through pain and addiction
Chromocell is developing innovative drugs to treat neuropathic and nociceptive pain without risk of addiction.
“WE BELIEVE OUR LEAD COMPOUND, CC8464, WILL PROVIDE THE FOUNDATION FOR SIGNIFICANT ADVANCES IN NON-OPIOID TREATMENT OF ERYTHROMELALGIA, EYE PAIN AND NEUROPATHIC PAIN.”